Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For DVA
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 20.08 1.43 1.19
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 4.94 18.45 17.58
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -9.74 10.55 11.69
Cash -23.11 4.05 5.27
Capex 21.64 -1.38 -1.76
Free Cash Flow -19.65 -2.91 3.63
Revenue 0.48 34.98 34.82
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 25.09 0.32 0.26
Operating Margin 20.72 0.16 0.13
ROA 60.78 0.01 < 0.005
ROE 81.41 0.26 0.14
ROIC -8.35 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of DVA is permitted for members.
5 Growth
The "Growth Entry" for the Focus of DVA is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of DVA is permitted for members.